Life Technologies Corp. Third Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Life Technologies Corporation (NASDAQ:LIFE) will unveil its latest earnings on Tuesday, October 25, 2011. Life Technologies is a global biotechnology tools company offering products that include systems, instruments, reagents, and custom services.

Life Technologies Corporation Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 88 cents per share, a rise of 1.1% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1. Between one and three months ago, the average estimate moved down. It has been unchanged at 88 cents during the last month. Analysts are projecting profit to rise by 4.5% versus last year to $3.71.

Past Earnings Performance: Last quarter, the company fell short of estimates by 0 cents, coming in at profit of 89 cents per share against a mean estimate of net income of 94 cents. The company fell in line with expectations in the first quarter.

Investing Insights: has a Stock Chart Technical Analysts Dream About.

Wall St. Revenue Expectations: On average, analysts predict $916.3 million in revenue this quarter, a rise of 5.5% from the year ago quarter. Analysts are forecasting total revenue of $3.75 billion for the year, a rise of 4.5% from last year’s revenue of $3.59 billion.

Analyst Ratings: Analysts are bullish on this stock with 10 analysts rating it as a buy, one rating it as a sell and four rating it as a hold.

A Look Back: In the second quarter, profit fell 13.7% to $95.5 million (52 cents a share) from $110.6 million (58 cents a share) the year earlier, missing analyst expectations. Revenue rose 4.1% to $941.1 million from $903.7 million.

Key Stats:

The decrease in profit in the second quarter broke a streak of three consecutive quarters of year-over-year profit increases. Net income rose 2.4% in the first quarter, 44.5% in the fourth quarter of the last fiscal year and more than twofold in the third quarter of the last fiscal year.

Revenue has risen the past four quarters. Revenue rose 1.2% in the first quarter from the year earlier, climbed 7% in the fourth quarter of the last fiscal year from the year-ago quarter and 8.3% in the third quarter of the last fiscal year.

Competitors to Watch: Techne Corporation (NASDAQ:TECH), Qiagen NV (NASDAQ:QGEN), Affymetrix, Inc. (NASDAQ:AFFX), Sigma-Aldrich Corporation (NASDAQ:SIAL), Thermo Fisher Scientific Inc. (NYSE:TMO), Strategic Diagnostics Inc. (NASDAQ:SDIX), Agilent Technologies Inc. (NYSE:A), Bio-Rad Laboratories, Inc. (NYSE:BIO), PerkinElmer, Inc. (NYSE:PKI), and Johnson & Johnson (NYSE:JNJ).

Stock Price Performance: During July 26, 2011 to October 19, 2011, the stock price had fallen $11.68 (-23.4%) from $49.83 to $38.15. The stock price saw one of its best stretches over the last year between December 9, 2010 and December 16, 2010 when shares rose for six-straight days, rising 7.3% (+$3.81) over that span. It saw one of its worst periods between July 22, 2011 and August 8, 2011 when shares fell for 12-straight days, falling 25.4% (-$13.09) over that span. Shares are down $17.35 (-31.3%) year to date.

(Source: Xignite Financials)

Investing Insights: has a Stock Chart Technical Analysts Dream About.